Johnson & Johnson earnings and sales topped Q2 views, but the Dow Jones health care giant cut full-year EPS targets. J&J stock edged lower.

The post Johnson & Johnson Earnings Top, But Dow Stock Falls On Lowered Guidance appeared first on Investor’s Business Daily.